REFERENCES
- DeBaun M, Vichinsky E. Hemoglobinopathies. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pennsylvania: Saunders Elsevier; 2007, pp. 2025–2032.
- Borgna-Pignatti C, Cappellini MD, De Stefano P, Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–47.
- Taher A, Isma'eel H, Mehio G, Prevalence of thromboembolic events among 8.860 patients with thalassemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488–491.
- Yeşilipek MA. Beta Talasemili Hastalarda Hematopoetik Kök Hücre Transplantasyonu. Türkiye Klinikleri 2003;1:13–22.
- Li CK, Chik KW, Wong GW, Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol. 2004;21:411–419.
- Banani SA, Omrani GH. Cortisol and adrenocorticotropic hormone response to surgical stress (splenectomy) in thalassemic patients. Pediatr Surg Int. 2000;16:400–403.
- Legault L, Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatr Transplant. 1999;3:60–66.
- Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with Thalassaemia Major. Pediatr Endocrinol Rev. 2007;5:642–648.
- Öcal G. Pubertal Fizyoloji. In: Günöz H, Öcal G, Yordam N, Kurtoğlu S, eds. Pediatrik Endokrinoloji. 1st ed. Ankara: Pediatrik Endokrinoloji ve Oksoloji Derneği Yayınları-1. 2003, pp. 137–189
- Tauchmanovà L, Selleri C, Rosa GD, High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer. 2002;95:1076–1084.
- Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 2008;41:223–227.
- Kattamis AC, Antoniadis M, Manoli I, Endocrine problems in ex-thalassemic patients. Transfus Sci. 2000;23:251–252.
- Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev. 2002;16:81–85.
- Piga A, Longo F, Voi V, Late effects of bone marrow transplantation for thalassemia. Ann N Y Acad Sci. 1998;850:294–299.
- Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175–184.
- Geffner ME, Karlsson H. Use of recombinant human growth hormone in children with thalassemia. Horm Res. 2009;71:46–50.
- Pratelli L, Verri E, Fortini M, Chelation therapy and bone metabolism markers in thalassemia major. J Pediatr Endocrinol Metab. 2006;19:1335–1342.
- Angelopoulos NG, Katounda E, Rombopoulos G, Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy X-ray absorptiometry and quantitative computed tomography: a comparison study. J Pediatr Hematol Oncol. 2006;28:73–78.
- Keilholz U, Max R, Scheibenbogen C, Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer. 1997;79:1617–1622.
- Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Thalassemia Clinical Research Network. Complications of beta-thalassemia major in North America. Blood. 2004;104:34–39.
- Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sang. 2000;79:129–137.
- De Sanctis V, Galimberti M, Lucarelli G, Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child. 1991;66:517–520.